Scharf Investments, LLC Novartis Ag Transaction History
Scharf Investments, LLC
- $3.25 Billion
- Q3 2024
A detailed history of Scharf Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Scharf Investments, LLC holds 1,277,793 shares of NVS stock, worth $124 Million. This represents 4.52% of its overall portfolio holdings.
Number of Shares
1,277,793
Previous 1,351,452
5.45%
Holding current value
$124 Million
Previous $144 Million
2.15%
% of portfolio
4.52%
Previous 4.48%
Shares
30 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.19 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.17 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$786 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$678 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$560 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $209B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...